KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Net Margin (2016 - 2025)

Cme (CME) has disclosed Net Margin for 17 consecutive years, with 70.84% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1422.0% to 70.84% in Q4 2025 year-over-year; TTM through Dec 2025 was 61.67%, a 487.0% increase, with the full-year FY2025 number at 61.67%, up 487.0% from a year prior.
  • Net Margin was 70.84% for Q4 2025 at Cme, up from 58.31% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 83.48% in Q3 2021 to a low of 43.28% in Q2 2021.
  • A 5-year average of 56.95% and a median of 56.54% in 2023 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: soared 4540bps in 2021, then plummeted -2882bps in 2022.
  • Cme's Net Margin stood at 52.81% in 2021, then decreased by -1bps to 52.16% in 2022, then grew by 7bps to 55.88% in 2023, then grew by 1bps to 56.62% in 2024, then rose by 25bps to 70.84% in 2025.
  • Per Business Quant, the three most recent readings for CME's Net Margin are 70.84% (Q4 2025), 58.31% (Q3 2025), and 59.82% (Q2 2025).